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Cancer cells have worked out numerous strategies to evade apoptosis by various 
approaches and make the established therapeutic regimens lose efficacy. 
Mitochondrial membrane permeabilization (MMP) is the decisive point of the 
irreversible process of cell apoptosis. Upon which, mitochondrial membrane 
potential(Δψm) is lost, cytochrome c and other pro-apoptotic factors are released from 
the mitochondrial intermembrane space into the cytosol, by which a caspase cascade 
is initiated and the cell is deliberately disassembled into apoptotic bodies. Cancer cells 
have the ability to block the signaling pathways that lie upstream of mitochondria and 
converge on mitochondria to trigger MMP, which may be the cause of resistance. 
Compared to conventional anticaner drugs, mitochondria-targeting anticancer drugs 
could directly trigger MMP and induce apoptosis through promoting the 
destabilization of mitochondrial lipids, interacting with permeability transition pore 
complex, inactivating anti-apoptotic members of the Bcl-2 family and forming DNA 
adducts. Thus, the mitochondria-targeting anticancer agents are receiving more 
attention in anticancer drug development. Establishment of rapid and high throughput 
detection method for the identification of mitochondria-targeting anticancer drugs can 
not only provide powerful pharmaceutical agents but also pave the way for 
accelerating the discovery of promising anticancer drugs.  
Δψm is an important parameter in anticancer drug analysis. Flow cytometry is 
widely applied in the rapid, specific, and multiparameter measurement of single cells 
and microscopic particles. However, upon treating isolated mitochondria with 
mitochondrially-targeted agents, the collapse of Δψm and the release of inter 
membrane space contents normally result in a much weaker signal both in 
















flow cytometry to perform single mitochondria analysis. To meet the demand of 
highly sensitive analysis, we have developed a high sensitivity flow cytometer 
(HSFCM) that is hundreds to thousands fold more sensitive than the conventional 
flow cytometer. HSFCM have already been successfully applied in systematic 
analysis of biological samples such as bacteria and mitochondria. 
Here, the high sensitivity of HSFCM is exploited for the rapid identification of 
mitochondria-targeting anticancer agents. First, we chose betulinic acid, paclitaxel, 
actinomycin D, cisplatin, ABT-737, antimycin A, curcumin, and triptolide to stimulate 
HeLa cells to ensure that these drugs could trigger apoptosis of HeLa cells. Then we 
optimized experimental conditions for drug stimulation and mitochondrial membrane 
potential analysis. Finally, we analyzed Δψm and mitochondrial morphology before 
and after drug treatment by the HSFCM. Our results agreed well with western blot 
analysisand literature reports. Moreover, we applied the established methods in the 
analysis of laboratory-synthesized compound (0560, 0610, 0746, 0765 provided by 
Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences) or anticancer 
peptide (LL-37, LZ1, LZ2 provided by Kunming Institute of Zoology, Chinese 
Academy of Sciences) and achieved good results. 
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新增病例和死亡人数出现惊人增长，中国首当其冲，全国每 6 分钟就有 1 人被确
























































图 1.1 癌细胞的特性 











































。以 Fas -FasL 为例，在 
细胞外死亡信号的作用下，死亡配体 FasL 与细胞膜表面的死亡受体 Fas 特异性
识别并结合，诱导 Fas 形成三聚体，并通过与接头蛋白 FADD 的结合（FADD 直
接与 Fas 受体的死亡结构域结合）招募 caspase 8 凋亡蛋白酶前体
[32-34]
。Caspase 8
前体寡聚化并通过自催化反应而激活，活化的 caspase 8 通过信号级联放大引发







图 1.2 细胞凋亡的外源和内源通路 
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